Discovery and structure–activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors-Reference-Cited by-同舟云学术

Discovery and structure–activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors

Published:2016-09 Issue:17 Volume:26 Page:4179-4183
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cooper Ian R.,McCarroll Andrew J.,McGarry David,Kirkham James,Pichowicz Mark,Walker Rolf,Warrilow Catherine,Salisbury Anne-Marie,Savage Victoria J.,Moyo Emmanuel,Forward Henry,Cheung Jonathan,Metzger Richard,Gault Zoe,Nelson Gary,Hughes Diarmaid,Cao Sha,Maclean John,Charrier Cédric,Craighead Mark,Best Stuart,Stokes Neil R.,Ratcliffe Andrew J.

Funder

Innovative Medicines Joint Undertaking

European Union

EFPIA

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference23 articles.

1. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations;O’Neill,2016

2. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

3. ESKAPEing the labyrinth of antibacterial discovery